Rockwell Medical Inc
NASDAQ:RMTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (16.1), the stock would be worth $-0.26 (131% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -52 | $0.85 |
0%
|
| Industry Average | 16.1 | $-0.26 |
-131%
|
| Country Average | 13.3 | $-0.22 |
-126%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Rockwell Medical Inc
NASDAQ:RMTI
|
33.3m USD | -52 | -6.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 39.4 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 16.1 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
91B DKK | 13.5 | 23.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 22.2 | 32.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 12.1 | 32.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 22.4 | 51.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 19.8 | -15.6 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.2T KRW | -88.6 | -37.2 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.7B CNY | 22.3 | 22.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Rockwell Medical Inc
Glance View
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.
